Gainers
- IsoPlexis ISO shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The company's, Q4 earnings came out today.
- Exicure XCUR shares rose 21.48% to $0.26. The market value of their outstanding shares is at $27.7 million.
- Organogenesis Holdings ORGO stock moved upwards by 15.05% to $8.33. The market value of their outstanding shares is at $1.0 billion. The company's, Q4 earnings came out yesterday.
- Brickell Biotech BBI stock moved upwards by 12.59% to $0.24. The market value of their outstanding shares is at $28.1 million.
- Ardelyx ARDX shares increased by 11.95% to $0.81. The market value of their outstanding shares is at $106.1 million. As per the press release, Q4 earnings came out 2 days ago.
- Aditxt ADTX stock moved upwards by 11.16% to $0.43. The market value of their outstanding shares is at $18.9 million.
Losers
- Karyopharm Therapeutics KPTI stock decreased by 27.7% to $7.51 during Wednesday's pre-market session. The market value of their outstanding shares is at $568.8 million.
- ChemoCentryx CCXI stock fell 13.41% to $25.51. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q4 earnings came out yesterday.
- HOOKIPA Pharma HOOK stock fell 10.32% to $2.26. The market value of their outstanding shares is at $70.7 million.
- Inovio Pharmaceuticals INO stock fell 10.19% to $2.91. The company's market cap stands at $612.2 million. The company's, Q4 earnings came out yesterday.
- Intercept Pharmaceuticals ICPT stock decreased by 9.0% to $13.65. The market value of their outstanding shares is at $403.3 million. As per the news, the Q4 earnings report came out today.
- Kodiak Sciences KOD shares fell 7.58% to $8.17. The company's market cap stands at $422.5 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in